Načítá se...
Valproate inhibits glucose-stimulated insulin secretion in beta cells
Valproate (VPA), an FDA approved anti-epileptic drug with a half-life of 12–18h in humans, has been shown to perturb the vacuolar proton pump (vH(+)-ATPase) function in yeasts by inhibiting myo-inositol phosphate synthase, the first and rate-limiting enzyme in inositol biosynthesis, thereby resultin...
Uloženo v:
| Vydáno v: | Histochem Cell Biol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6719693/ https://ncbi.nlm.nih.gov/pubmed/30145684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00418-018-1713-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|